Diagnostic utility of plasma translocator protein 18 kDa (TSPO) in sepsis: A case–control study

Miyuki Hattori,Kazuya Kikutani,Koji Hosokawa,Michihito Kyo,Mitsuaki Nishikimi,Kohei Ota,Shinichiro Ohshimo,Hidenori Aizawa,Nobuaki Shime
DOI: https://doi.org/10.1097/md.0000000000040396
IF: 1.6
2024-11-06
Medicine
Abstract:Translocator protein 18 kDa (TSPO) is a mitochondrial membrane protein that is involved in inflammation, oxidative stress, and steroidogenesis. [ 1 , 2 ] It is well-known for its expression in microglia of the brain, but it is also present in various organs throughout the body. [ 3 ] In normal brain tissue, TSPO expression is low, but it significantly increases in response to brain injury or inflammation. [ 3 ] Given that it is preferentially expressed in activated microglia and macrophages, it is understood to be related to neuroinflammation associated with such as Alzheimer diseases and Parkinson diseases. [ 2 , 4 ] Furthermore, the development of radioligands targeting TSPO has led to its use in PET-based imaging. [ 5 , 6 ]
medicine, general & internal
What problem does this paper attempt to address?